National Comprehensive Cancer Network



About NCCN

Neuroendocrine Tumors Panel - Disclosures as of 4/4/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Al B. Benson III, MD, FACP, FASCO

None

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Enzon Pharmaceuticals;
Genentech, Inc.;
General Electric;
Genomic Health, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

None

Jordan D. Berlin, MD

None

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Merck & Co., Inc.;
Agensys/Seattle Genetics;
Clovis;
Roche Laboratories, Inc.;
Schering-Plough Corporation

None

None

None

Lawrence S. Blaszkowsky, MD

Genentech, Inc.

Bristol-Myers Squibb Company;
Pfizer Inc.

None

None

None

Michael A. Choti, MD, MBA

None

Genentech, Inc.;
sanofi-aventis U.S.

None

None

None

Orlo H. Clark, MD

None

None

None

None

None

Gerard M. Doherty, MD

None

Novartis Pharmaceuticals Corporation

None

None

None

Mary Dwyer, MS

None

None

None

None

None

James Eason, MD

None

None

None

None

None

Lyska Emerson, MD

None

None

None

None

None

Paul F. Engstrom, MD, FACP

None

None

None

None

None

Deborah Freedman-Cass, PhD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

John F. Gibbs, MD, FACS, MHCM

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Martin J. Heslin, MD

None

None

None

None

None

Fouad Kandeel, MD, PhD

None

Molecular Insights Pharmaceuticals

None

None

None

Anne Kessinger, MD

Pharmacyclics;
sanofi-aventis U.S.

None

None

None

None

Matthew H. Kulke, MD

None

Novartis Pharmaceuticals Corporation;
Ipsen;
Lexicon;
Pfizer Inc.

None

None

None

Pamela L. Kunz, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Jeffrey F. Moley, MD

None

None

None

None

None

John A. Olson, MD, PhD

None

None

None

None

None

Venu G. Pillarisetty, MD

None

None

None

None

None

Leonard Saltz, MD

None

Abbott Laboratories;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Genzyme Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Asuragen, Inc.;
Roche Laboratories, Inc.;
YM BioScience Inc.

None

None

None

Manisha H. Shah, MD

None

Novartis Pharmaceuticals Corporation

None

None

None

Jonathan R. Strosberg, MD

Pfizer Inc.

Endo Pharmaceuticals

None

None

None

Jean-Nicolas Vauthey, MD

None

None

None

None

None

James C. Yao, MD

None

National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Endo;
Ipsen;
Pfizer Inc.

None

None

None